Vertex Pharmaceuticals (VRTX) Gross Profit Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.76% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 16.94% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,488.21% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.76% |
| Dec 31, 2025 | 9.46% |
| Sep 30, 2025 | 11.86% |
| Jun 30, 2025 | 12.47% |
| Mar 31, 2025 | 2.52% |
| Dec 31, 2024 | 15.76% |
| Sep 30, 2024 | 9.91% |
| Jun 30, 2024 | 4.08% |
| Mar 31, 2024 | 11.39% |
| Dec 31, 2023 | 6.45% |
| Sep 30, 2023 | 5.86% |
| Jun 30, 2023 | 12.93% |
| Mar 31, 2023 | 13.84% |
| Dec 31, 2022 | 10.64% |
| Sep 30, 2022 | 17.01% |
| Jun 30, 2022 | 23.57% |
| Mar 31, 2022 | 20.87% |
| Dec 31, 2021 | 28.11% |
| Sep 30, 2021 | 29.25% |
| Jun 30, 2021 | 16.82% |
| Mar 31, 2021 | 13.26% |
| Dec 31, 2020 | 4,977.17% |
| Sep 30, 2020 | 65.31% |
| Jun 30, 2020 | 66.34% |
| Mar 31, 2020 | 77.20% |
| Dec 31, 2019 | -103.91% |
| Sep 30, 2019 | 21.48% |
| Jun 30, 2019 | 24.36% |
| Mar 31, 2019 | 34.11% |
| Dec 31, 2018 | 31.75% |
| Sep 30, 2018 | 33.25% |
| Jun 30, 2018 | 36.97% |
| Mar 31, 2018 | -14.76% |
| Dec 31, 2017 | 42.23% |
| Sep 30, 2017 | 41.75% |
| Jun 30, 2017 | 23.97% |
| Mar 31, 2017 | 91.72% |
| Dec 31, 2016 | 15.85% |
| Sep 30, 2016 | 30.94% |
| Jun 30, 2016 | 153.21% |